Specialized Self-Emulsifying Cannabidiol Formulations for Niche Applications
Legal Citation
Summary of the Inventive Concept
This inventive concept adapts self-emulsifying cannabidiol formulations for specific, narrow markets or unique operational environments, such as treating opioid addiction, chronic pain in chemotherapy patients, veterinary use, anxiety disorders in children, and sleep disorders in the elderly.
Background and Problem Solved
The original patent disclosed self-emulsifying cannabidiol compositions for general therapeutic applications. However, certain niche markets or operational environments require specialized formulations that address specific challenges, such as extreme temperatures, pediatric or veterinary use, or specific disease indications. The present inventive concept addresses these limitations by providing tailored formulations for these unique applications.
Detailed Description of the Inventive Concept
The new inventive concept comprises self-emulsifying cannabidiol formulations adapted for specific niche applications. Claim 1 addresses opioid addiction by incorporating an opioid receptor antagonist. Claim 2 targets chronic pain in chemotherapy patients by formulating the composition to withstand extreme temperatures. Claim 3 is designed for veterinary use, incorporating a flavoring agent. Claim 4 addresses anxiety disorders in children, utilizing a pediatric-friendly excipient. Claim 5 focuses on treating sleep disorders in the elderly, incorporating a sleep-promoting agent. These specialized formulations ensure optimal performance and efficacy in their respective applications.
Novelty and Inventive Step
The novelty of this inventive concept lies in the adaptation of self-emulsifying cannabidiol formulations for specific, narrow markets or unique operational environments. The inventive step resides in the selection of specific components, such as opioid receptor antagonists, flavoring agents, pediatric-friendly excipients, or sleep-promoting agents, which enable the formulations to address the particular challenges of each niche application.
Alternative Embodiments and Variations
Alternative embodiments of this inventive concept could include formulations adapted for disaster relief, high-security needs, or extreme weather conditions. Variations could involve different surfactants, oils, or antioxidants to optimize performance in specific applications.
Potential Commercial Applications and Market
This inventive concept has significant commercial potential in various industries, including pharmaceuticals, veterinary medicine, and nutraceuticals. The specialized formulations can be marketed to address specific therapeutic needs, such as opioid addiction, chronic pain, anxiety disorders, or sleep disorders, in various patient populations.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/107 |
| A | A61 | A61K9/4808 |
| A | A61 | A61K9/4825 |
| A | A61 | A61K31/05 |
| A | A61 | A61K47/10 |
| A | A61 | A61K47/14 |
| A | A61 | A61K47/22 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical formulations, specifically cannabidiol delivery systems, with expertise in self-emulsifying drug delivery technologies, surfactant interactions, and specialized medical compositions
Person of Ordinary Skill (PHOSITA) Profile
A pharmaceutical formulation scientist with advanced degree in pharmaceutical sciences or chemical engineering, experienced in drug delivery systems, familiar with cannabinoid formulation techniques, surfactant interactions, and excipient selection
Obviousness Rationale
A skilled practitioner would recognize that the source patent's self-emulsifying cannabidiol composition provides a foundational framework that can be readily adapted for specific medical applications by incorporating targeted therapeutic agents or modifying excipient compositions. The PTD's variations represent predictable extensions of the original formulation technology, utilizing standard pharmaceutical engineering techniques to address specific patient populations or treatment scenarios. The core self-emulsification technology remains consistent, with modifications representing routine optimization within the field.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,678 |
|---|---|
| Title | Self-emulsifying cannabidiol formulations |
| Assignee(s) | Benuvia Operations, LLC |